Li Z, Wu C F, Pei G, Guo Y Y, Li X
Department of Pharmacology, Shenyang Pharmaceutical University, 110015, Shenyang, People's Republic of China.
Pharmacol Biochem Behav. 2000 Jul;66(3):595-601. doi: 10.1016/s0091-3057(00)00260-4.
The antagonistic effect of pseudoginoside-F11 (PF(11)) on the various actions of morphine was studied in mice. The results demonstrated that PF(11), at the doses of 4 and 8 mg/kg, PO, significantly inhibited morphine (10 mg/kg, SC)-induced memory impairment in the Morris water maze test. PF(11), at 4 mg/kg, PO, did not influence conditioned place preference per se, yet markedly blocked the conditioned place preference to morphine. PF(11), at the doses of 4 and 8 mg/kg, PO, also significantly antagonized morphine (5 mg/kg, SC)-induced analgesia tested by tail pinch method. PF(11), at 4 mg/kg, PO, did not influence locomotor activity per se, yet inhibited the development of the reverse tolerance, as shown by the increase in locomotor activity, to morphine. At the doses of 4 and 8 mg/kg, PO, PF(11) significantly antagonized the development of analgesia tolerance to morphine in the tail pinch test. Thus, the above results demonstrate for the first time that PF(11) can antagonize some actions of morphine. However, the mechanism of action of PF(11) merits further evaluation.
在小鼠中研究了假人参皂苷-F11(PF(11))对吗啡各种作用的拮抗作用。结果表明,在口服剂量为4和8 mg/kg时,PF(11)显著抑制了在莫里斯水迷宫试验中吗啡(皮下注射10 mg/kg)诱导的记忆损伤。口服4 mg/kg的PF(11)本身不影响条件性位置偏爱,但显著阻断了对吗啡的条件性位置偏爱。口服剂量为4和8 mg/kg的PF(11)也显著拮抗了通过夹尾法检测的吗啡(皮下注射5 mg/kg)诱导的镇痛作用。口服4 mg/kg的PF(11)本身不影响自发活动,但抑制了对吗啡的反向耐受性的发展,表现为自发活动增加。在口服剂量为4和8 mg/kg时,PF(11)在夹尾试验中显著拮抗了对吗啡镇痛耐受性的发展。因此,上述结果首次证明PF(11)可拮抗吗啡的某些作用。然而,PF(11)的作用机制值得进一步评估。